Rheumatoid Arthritis Clinical Trials in Philadelphia

Showing 521-540 of 1,834 trials

HITT for the Identification of Mild Traumatic Brain Injury

NCT05092282

Rebion has developed a device, the Rebion trauma tool (referred to as the head and intraocular trauma tool, or "HITT"), that detects ocular fixation and alignment using a binocular retinal scan. Preliminary data obtained from hospitalized patients with a clinically-confirmed traumatic brain injury (TBI) and uninjured controls indicates that the device can detect changes in ocular fixation, alignment, and saccades that are related to brain injury. This study seeks to evaluate the ability of the Rebion trauma tool to assess perturbations in eye movements resulting from TBI. The study will enroll 100 TBI patients and 100 controls.

Brain Injuries, Traumatic

Rebiscan, Inc.200 participantsStarted Aug 2021

Philadelphia, Pennsylvania, United States

RECRUITINGNA< 1 mile

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

NCT05237258

This research study is evaluating whether primary palliative care is an alternative strategy to specialty palliative care for improving quality of life, symptoms, mood, coping, and end of life outcomes in patients with acute myeloid leukemia (AML).

Relapsed Adult AMLPrimary Refractory Acute Myeloid LeukemiaHigh Risk Acute Myeloid Leukemia

Massachusetts General Hospital2,300 participantsStarted Jun 2022

Birmingham, Alabama, United States • Stanford, California, United States • Denver, Colorado, United States +17 more locations

HITT for the Identification of Mild Traumatic Brain Injury

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

Rheumatoid Arthritis Trials in Other Cities

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)

Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis

Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation

The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors

OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD)

International CIPN Assessment and Validation Study

M6-C Post Approval Study (PAS)

Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

A Study to Compare Nighttime Aligners to Daytime Aligners

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications

9-ING-41 in Pediatric Patients With Refractory Malignancies.

A Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants With Relapsed or Refractory Multiple Myeloma

A Post-market Clinical Study to Collect Safety and Performance Data on Johnson & Johnson Surgical Vision Products

LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)

Other Conditions in Philadelphia